New study to help prevent lifestyle-related diseases in India

Image
Press Trust of India Melbourne
Last Updated : Aug 25 2015 | 6:07 PM IST
Public health experts from Australia and India will collaborate on new research about non-communicable, lifestyle-related ailments such as diabetes, heart disease, stroke and cancers in India and other countries in South Asia.
ENCORE - Excellence in NonCOmmunicable disease REsearch - will train a new generation of researchers in non-communicable disease prevention and control in India and other low- and middle-income countries in South Asia.
ENCORE project lead Professor Brian Oldenburg said that the principal causes of deaths in the world are now lifestyle-related.
"Chronic, non-communicable conditions like heart disease, stroke, diabetes and cancers have become the leading causes of deaths in the developing world. Today, 80 per cent of these deaths are people from low- and middle-income countries like India," he said.
"To address the burden of chronic conditions, there is an urgent need for more research to improve disease prevention and management," Oldenburg said.
ENCORE will be co-led by senior researchers from the University of Melbourne and India's top public health and medical research institutes.
The collaboration partners are: the University of Melbourne; the Public Health Foundation of India; All India Institute of Medical Sciences (AIIMS); Christian Medical College and Hospital (Vellore); and Sree Chitra Tirunal Institute for Medical Sciences and Technology.
Professor K R Thankappan from Sree Chitra Tirunal Institute in Kerala said that the collaboration will be very significant over the next three years.
"We anticipate involving almost 40 doctoral and postdoctoral students from the Australian and Indian collaborating partner institutions," he said.
"Trainees will undertake research exchange, participate in online web conferences, take advanced subjects at one another institutions, participate in annual workshops, attend international conferences and undertake exchanges with top research institutes in the US and UK," Thankappan said.
Announcing that the University of Melbourne will fund the ENCORE project over the next three years, Vice-Chancellor Glyn Davis said it was an outstanding example of collaboration between India and Australia.
"India is such an important research partner for Australia and ENCORE is one of a number of high quality collaborations the University of Melbourne and our Indian partners have established in recent years," said Davis.
"In ENCORE there is such a wonderful opportunity to work together with policy makers, clinicians and other health professionals in India to help curb the spread of non-communicable diseases in India and in other countries throughout Asia," Davis said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 25 2015 | 6:07 PM IST

Next Story